ArticleJHEP reports : innovation in hepatology2022

B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.

Maaike Biewenga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.